PPT-Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular
Author : paige | Published Date : 2024-01-03
Slide deck The full text of the paper is available at httpwwwthelancetcomjournalslancetarticlePIIS0140673618316520fulltext Rationale Lipoprotein a is an established
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Baseline and on-statin treatment lipopro..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular: Transcript
Slide deck The full text of the paper is available at httpwwwthelancetcomjournalslancetarticlePIIS0140673618316520fulltext Rationale Lipoprotein a is an established risk. Louis H. Stein, Jessica Berger, Maryann . Tranquilli. , . John A. . Elefteriades. .. . The Aortic Institute at Yale – New Haven Hospital . Bench top to bedside interaction. . Medial Degeneration . Dyslipidemia. . Treatment. USA-145-101385. © . 2014 . Amgen Inc. All rights reserved. Not for Reproduction. . Table of Contents. Dyslipidemia. Dyslipidemia in . Diabetes. Dyslipidemia in Familial Hypercholesterolemia. Guidelines for Management of Dyslipidemia . and Prevention of Cardiovascular Disease. Writing Committee. . Chair. : Paul S. Jellinger, MD, MACE. Co-Chair. : Yehuda Handelsman, MD, FACP, FACE. Members. James J. Lehman, DC, MBA, FACO. Associate Professor of Clinical Sciences. School of Chiropractic. Director. Community Health Clinical Education. University of Bridgeport. Learning Objectives. . Organize a clinical thought process while performing a neuromusculoskeletal evaluation of a patient with statin myopathy and piriformis syndrome.. Diagnosis, Prevention and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016) G.B. John Mancini, MD, Steven Baker, MD, Jean Bergeron, MD, David Fitchett, MD, Result. . from the . P. rogression of . A. the. R. osclerotic. . Pl. A. que. . D. eterm. I. ned. by Computed . Tomo. G. raphic. Angiography . I. M. aging. (PARADIGM) study. Sang-Eun Lee, . Hyuk-Jae Chang. Evidence from . meta-analyses of . Mendelian. . randomization. studies. , . prospective. cohort studies. , . and. . randomized. . controlled. trials . unequivocally establishes that LDL causes ASCVD. Control. Relative risk. Absolute Effect. (per thousand). Statin. Myalgia. 348/14960. (2.3%) . 288/14520. (2.0%). 1.02. (0.88-1.19). +1. (-1 to +5). Rhabdomyolysis. 138/2454. (5.6%). 158/2446. (6.5%). of the NLA. Conclusions of the NLA Safety Task Force for Muscle Safety. Myopathy and rhabdomyolysis are associated with statin therapy, as a class effect. Elevated creatine kinase (CK) levels may indicate statin-induced muscle damage. Simplied lipid guidelinesPrevention and management of cardiovascular disease in primary care EDITORS KEY POINTS Clinical practice guidelines are often developed with little input from the in women (IJCD) 2016 VOL 1 ISSUE 2 CASE REPORTS ARTICLE 1 WINCARS ABSTRACT Statins are a class of hypolipidemic drugs, that are primarily used for the treatment of dyslipidemia and the prevention of Lipoprotein Metabolism. Dr. . Usman. . Ghani. Objectives. By the end of this lecture, the First Year students will be able to:. Define and list the types, structure and composition of . lipoproteins. Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy. Dr. Sonalika’s Eye Clinic provide the best Eye infection treatment, Conjunctivitis treatment in pune, Hadapsar, Amanora, Magarpatta, Mundhwa, Kharadi Rd, Viman Nagar, Wagholi, and Wadgaon Sheri
Download Document
Here is the link to download the presentation.
"Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents